Cyclobenzaprine Hydrochloride - CAS# 6202-23-9 ydrochelerythrine InChi: InChI=1S/C21H25N3O3S/c25-14-16-27-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)28(26)20-8-4-2-6-18(20)22-21/h1-8

InChi: InChI=1S/C21H25N3O3S/c25-14-16-27-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)28(26)20-8-4-2-6-18(20)22-21/h1-8

InChi: InChI=1S/C45H54N4O8/c1-8-27-19-28-22-44(40(51)55-6

InChi: InChI=1S/C19H23F2N5O2/c1-10(2)5-6-26-11(3)18(28)25(4)15-9-22-19(24-17(15)26)23-12-7-13(20)16(27)14(21)8-12/h7-11

890190-22-4

was identified as a potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor with an excellent pharmacokinetic profile amenable for once-weekly human dosing and selected as a clinical development candidate

Cyclobenzaprine Hydrochloride - CAS# 6202-23-9 ydrochelerythrine InChi: InChI=1S/C21H25N3O3S/c25-14-16-27-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)28(26)20-8-4-2-6-18(20)22-21/h1-8Cyclobenzaprine, also known as Flexeril, is a muscle relaxer medication used to relieve skeletal muscle spasms and associated pain in acute musculoskeletal conditions. It is the best studied drug for this application. It has also been used off label for fibromyalgia treatment. A new sublingual formulation of cyclobenzaprine is under development for the chronic management of fibromyalgia syndrome. The exact mechanism of action of cyclobenzaprine has